Профиль Gan & Lee Pharmaceuticals Co., Ltd. Registered Shs -A-
Gan & Lee Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of recombinant insulin analogue raw materials and injections. Its products include recombinant insulin glargine injections, recombinant insulin lispro injections, protamine zinc recombinant insulin lispro mixed injections, and injection pens and needles. The company was founded by Zhong Ru Gan on June 17, 1998 and is headquartered in Beijing, China.